P-393 A real-world UK experience of Daratumumab, Velcade, Dexamethasone and Carfilzomib, Lenalidomide, Dexamethasone as second line therapies in the UK: a South East London retrospectiveDogan Yildiz, Arief Gunawan, Katharine Bailey et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 0
Safety and Efficacy of Dara-VTD Induction and Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients Presenting with Renal Failure - a Tertiary Centre UK Experience on Behalf of the UK-MRAAdrian Maraj, Kirsty Cuthill, Katharine Bailey et al.|Blood|2024Cited by 0